Outcome Measures Used in Ocular Gene Therapy Trials: A Scoping Review of Current Practice

by Jasleen K. Jolly, Jasleen K. Jolly, Jasleen K. Jolly, Holly Bridge, Robert E. MacLaren, Robert E. MacLaren
Published 2019-09-01

The Clinical Use of Vernier Acuity: Resolution of the Visual Cortex Is More Than Meets the Eye

by Monica L. Hu, Lauren N. Ayton, Lauren N. Ayton, Jasleen K. Jolly, Jasleen K. Jolly
Published 2021-10-01

Structural and Functional Characteristics of Color Vision Changes in Choroideremia

by Jasleen K. Jolly, Jasleen K. Jolly, Jasleen K. Jolly, Matthew P. Simunovic, Matthew P. Simunovic, Adam M. Dubis, Amandeep S. Josan, Amandeep S. Josan, Anthony G. Robson, Anthony G. Robson, Marco P. Bellini, Edward Bloch, Odysseas Georgiadis, Lyndon da Cruz, Holly Bridge, Robert E. MacLaren, Robert E. MacLaren
Published 2021-10-01

Novel Pathogenic Sequence Variants in <i>NR2E3</i> and Clinical Findings in Three Patients

by Saoud Al-khuzaei, Suzanne Broadgate, Stephanie Halford, Jasleen K. Jolly, Morag Shanks, Penny Clouston, Susan M. Downes
Published 2020-10-01

Real-world refractive outcomes of toric intraocular lens implantation in a United Kingdom National Health Service setting

by Kanmin Xue, Jasleen K. Jolly, Sonia P. Mall, Shreya Haldar, Paul H. Rosen, Robert E. MacLaren
Published 2018-02-01

Longitudinal Study to Assess the Quantitative Use of Fundus Autofluorescence for Monitoring Disease Progression in Choroideremia

by Adam M Dubis, Wei S Lim, Jasleen K Jolly, Maria Toms, Robert E MacLaren, Andrew R Webster, Mariya Moosajee
Published 2021-01-01